Assembly Biosciences Files 8-K
Ticker: ASMB · Form: 8-K · Filed: Aug 8, 2025 · CIK: 1426800
| Field | Detail |
|---|---|
| Company | Assembly Biosciences, INC. (ASMB) |
| Form Type | 8-K |
| Filed Date | Aug 8, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting
TL;DR
Assembly Bio filed a standard 8-K, no major news.
AI Summary
Assembly Biosciences, Inc. filed an 8-K on August 8, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Assembly Biosciences, Inc. without disclosing specific material events or financial updates.
Risk Assessment
Risk Level: low — The filing is a routine 8-K with no disclosed material events, indicating no immediate new risks.
Key Players & Entities
- Assembly Biosciences, Inc. (company) — Registrant
- August 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-35005 (commission_file_number) — SEC File Number
- Two Tower Place, 7th Floor, South San Francisco, California 94080 (address) — Principal Executive Offices
- (833) 509-4583 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of August 8, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is August 8, 2025.
In which state is Assembly Biosciences, Inc. incorporated?
Assembly Biosciences, Inc. is incorporated in Delaware.
What is the SEC file number for Assembly Biosciences, Inc.?
The SEC file number for Assembly Biosciences, Inc. is 001-35005.
What is the address of Assembly Biosciences, Inc.'s principal executive offices?
The address of Assembly Biosciences, Inc.'s principal executive offices is Two Tower Place, 7th Floor, South San Francisco, California 94080.
Filing Stats: 760 words · 3 min read · ~3 pages · Grade level 11.1 · Accepted 2025-08-08 08:24:47
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 ASMB The Nasdaq Global Select Marke
Filing Documents
- d802767d8k.htm (8-K) — 27KB
- d802767dex991.htm (EX-99.1) — 34KB
- 0001193125-25-176138.txt ( ) — 182KB
- asmb-20250808.xsd (EX-101.SCH) — 3KB
- asmb-20250808_lab.xml (EX-101.LAB) — 18KB
- asmb-20250808_pre.xml (EX-101.PRE) — 11KB
- d802767d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Assembly Biosciences, Inc. Date: August 8, 2025 By: /s/ John O. Gunderson John O. Gunderson VP, General Counsel and Corporate Secretary